Prognostic factors for extra-abdominal and abdominal wall desmoids: A 20-year experience at a single institution

Journal of Surgical Oncology

Volumn 100, Issue 7, 2009, Pages 563-569

  Huang, Kai ^a,b   Fu, Hong ^a,b   Shi, Ying Qiang ^a,b   Zhou, Ye ^a,b   Du, Chun Yan ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Desmoids; Prognostic factors; Recurrence; Surgery

Indexed keywords

DOXORUBICIN; TAMOXIFEN;

ABDOMINAL FIBROMATOSIS; ADJUVANT THERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL OBSERVATION; DISEASE CONTROL; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GENDER; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NERVE SHEATH TUMOR; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SCHOOL CHILD; TUMOR LOCALIZATION; TUMOR RECURRENCE; TUMOR VOLUME;

ABDOMINAL NEOPLASMS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; EXTREMITIES; FEMALE; FIBROMATOSIS, ABDOMINAL; FIBROMATOSIS, AGGRESSIVE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL RATE; THORACIC NEOPLASMS; YOUNG ADULT;

EID: 71549117268     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21384     Document Type: Article

References (29)

1. Papagelopoulos P, Mavrogenis A, Mitsiokapa E, et al.: Current trends in the management of extra-abdominal desmoid tumours. World J Surg Oncol 2006;4:21-28. (Pubitemid 43750694)
2. Micke O, Seegenschmiedt MH: Radiation therapy for aggressive fibromatosis (desmoids tumors): Results of a national Patterns of Care Study. Int J Radiat Oncol Biol Phys 2005;61:882-891. (Pubitemid 40247987)
3. Sakorafas C, Nissotakis G, Peros GH: Abdominal desmoid tumors. Surg Oncol 2007;16:131-142.
4. KulaylatMN, Karakousis CP, Keaney CM, et al.: Desmoid tumour: A pleomorphic lesion. Eur J Surg Oncol 1999;25:487-497.
5. Easter DW, Halasz NA: Recent trends in the management of desmoid tumors. Summary of 19 cases and review of the literature. Ann Sug 1989;210:765-769.
6. Hayry P, Reitamo JJ, Totterman S, et al.: The desmoid tumor: Analysis of factors possibly contributing to the etiology and growth behavior. Am J Clin Pathol 1982;77:674-680. (Pubitemid 12073162)
7. Church JM: Desmoid tumors in patients with familial adenomatous polyposis. Semin Colon Rectal Surg 1995;6:29-32.
8. Pritchard DJ, Nascimento AG, Petersen IA: Local control of extra-abdominal desmoid tumors. J Bone Joint Surg 1996;78: 848-854.
9. Posner MC, Shiu MH, Newsome JL, et al.: The desmoid tumor: Not a benign disease. Arch Surg 1989;124:191-196.
10. Rodriguez-Bigas MA, Mahoney MC, Karakousis CP, et al.: Desmoid tumors in patients with familial adenomatous polyposis. Cancer 1994;74:1270-1274. (Pubitemid 24301779)
11. Gronchi A, Casali PG, Mariani L, et al.: Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: A series of patients surgically treated at a single institution. J Clin Oncol 2003;21:1390-1397. (Pubitemid 46606421)
12. Lev D, Kotilingam D, Wei C, et al.: Optimizing treatment of desmoid tumors [J]. J Clin Oncol 2007;25:1785-1791.
13. Merchant NB, Lewis JJ, Woodruff JM, et al.: Extremity and trunk desmoid tumors: A multifactorial analysis of outcome. Cancer 1999;86:2045-2052.
14. Goy BW, Lee SP, Eilber F, et al.: The role of adjuvant radiotherapy in the treatment of respectable desmoid tumors. Int J Radiat Oncol Biol Phys 1997;39:659-665. (Pubitemid 27441433)
15. Reitamo JJ, Scheinin TM, Häyry P: The desmoid syndrome: New aspects in the cause, pathogenesis and treatment of the desmoid tumor. Am J Surg 1986;151:230-237. (Pubitemid 16107305)
16. Sorensen A, Keller J, Nielsen OS, et al.: Treatment of aggressive fibromatosis: A retrospective study of 72 patients followed for 1-27 years. Acta Orthop Scand 2002;73:213-219. (Pubitemid 34557064)
17. Nuyttens JJ, Rust PF, Thomas CR, Jr., et al.: Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: A comparative review of 22 articles. Cancer 2000;88:1517-1523. (Pubitemid 30183134)
18. Spear MA, Jennings LC, Mankin HJ, et al.: Individualizing management of aggressive fibromatoses. Int J Radiat Oncol Biol Phys 1998;40:637-645.
19. Leithner A, Gapp M, Leithner K, et al.: Margins in extra-abdominal desmoid tumors: A comparative analysis. J Surg Oncol 2004;86:152-156. (Pubitemid 38720766)
20. Miralbel LR, Suit HD, Mankin HJ, et al.: Fibromatoses: From postsurgical surveillance to combined surgery and radiation therapy. Int J Radiat Oncol Biol Phys 1990;18:535-540.
21. Sherman NE, Romsdahl M, Evans H, et al.: Desmoid tumors: A 20-year radio-therapy experience. Int J Radiat Oncol Bio Phys 1990;19:37-40. (Pubitemid 20239782)
22. Ballo MT, Zagars GK, Pollack A, et al.: Desmoid tumor: Prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol 1999;17: 158-167. (Pubitemid 29022389)
23. Rock MG, Pritchard DJ, Reiman HM, et al.: Extra-abdominal desmoid tumors. J Bone Joint Surg Am 1984;66:1369-1374.
24. Gunderson LL, Nagorney DM, McIlrath DC, et al.: External beam and intraoperative electron irradiation for locally advanced soft tissue sarcomas. Int J Radiat Oncol Biol Phys 1993;25:647-656. (Pubitemid 23099258)
25. Hansmann A, Adolph C, Vogel T, et al.: High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors. Cancer 2004; 100:612-620. (Pubitemid 38128287)
26. Mace J, Sybil BJ, Sondak V, et al.: Response of extra-abdominal desmoid tumors to therapy with imatinib mesylate. Cancer 2002; 95:2373-2379. (Pubitemid 35351145)
27. Heinrich MC, McArthur GA, Demetri GD, et al.: Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor). J Clin Oncol 2006;24:1195-1203. (Pubitemid 46638818)
28. Lewis JJ, Boland PJ, Leung DH, et al.: The enigma of desmoid tumors. Ann Surg 1999;229:866-872.
29. Bonvalot S, Eldweny H, Haddad V, et al.: Extra-abdominal primary fibromatosis: Aggressive management could be avoided in a subgroup of patients. Eur J Surg Oncol 2008;34:462-468.